Tag: chronic ischaemic cardiovascular disease
BioVentrix receives FDA expanded access program approval for ischemic heart failure...
BioVentrix, a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated left ventricle and reverse...
Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised...
Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months, reports a European Society of Cardiology (ESC) study...